Website stats for Biopharmadive - biopharmadive.com
Lisa Maree Williams via Getty Images What to watch at next week's FDA meeting on COVID- vaccines for kids The outcome of a high-stakes advisory panel Tuesday could open the door for millions of kids to receive Pfizer's coronavirus vaccin...
biopharmadive.com was registered 1 decade 1 year ago. It has a alexa rank of #188,534 in the world. It is a domain having .com extension. It is estimated worth of $ 66,000.00 and have a daily income of around $ 110.00. As no active threats were reported recently, biopharmadive.com is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | 8,836 |
| Daily Pageviews: | 44,180 |
Estimated Valuation
| Income Per Day: | $ 110.00 |
| Estimated Worth: | $ 66,000.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | 188,534 |
| PageSpeed Score: | 89 ON 100 |
| Domain Authority: |
49 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
172.67.72.5
Hosted Country:
US
Location Latitude:
37.7757Location Longitude:
-122.395Traffic Classification
| Total Traffic: | 227.53K |
| Direct Traffic: | 29.90% |
| Referral Traffic: | 9.02% |
| Search Traffic: | 51.09% |
| Social Traffic: | 8.73% |
| Mail Traffic: | 0.78% |
| Display Traffic: | 0.48% |
Search Engine Results For biopharmadive.com
BioPharma Dive - Home | Facebook
BioPharma Dive, Washington D.C. 14328 likes · 21 talking about this. We provide business journalism and in-depth insight into the most impactful news...
ASBPE - BioPharma Dive
Issue or publication date: BioPharma Dive is a digital-only publication that posts original journalism articles to its website and via an email newsletter ...
BioPharma Dive - Overview, News & Competitors | ZoomInfo.com
View BioPharma Dive (www.biopharmadive.com) location in New York, United States , revenue, industry and description. Find related and similar companies as ...
BioPharma Dive | Future Pharma 2022
BioPharma Dive is the mobile friendly industry dashboard for biotech and pharma executives. We curate the industry's most important news,social commentary, ...
New database from BioPharma Dive designed to help you analyze ...
New database from BioPharma Dive designed to help you analyze the current boom in biotech IPOs. Emerging biotechs have been setting and breaking records for ...
BioPharma Dive: Contact Information, Journalists, and Overview
Use Muck Rack to learn more about BioPharma Dive and connect with journalists at BioPharma Dive.
Eli Lilly fires back against HHS order to repay providers for...
May 21, 2021 ... Related Publications. BioPharma Dive · MedTech Dive. Follow. Twitter · Facebook · LinkedIn · RSS. Feedback. Work email: * Message: *. S...
Sherkow quoted in BioPharma Dive on FDA scrutiny over gene ...
Nov 10, 2020 ... Professor Jacob Sherkow was quoted in an industry publication, BioPharma Dive, on what appears to be increased scrutiny from the FDA over ...
BioPharma Dive launches weekly pharma marketing and drug ...
Jan 4, 2016 ... The team at Industry Dive is proud to announce the launch of two new weekly editions of BioPharma Dive, BioPharma Dive: Manufacturing and ...
Use of convalescent plasma in COVID-19 - National Blood Authority
Nov 9, 2020 ... 9 https://www.biopharmadive.com/news/uniqure-hemophilia-b-gene-therapy-hope-trial/589336/. 10 In major surprise, FDA rejects high-profile ...
BioPharma Dive: Biotech and Pharma Industry News
BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development ...
Biogen sales face pressure from slow uptake of Alzhiemer's drug
4 days ago ... Picture for Novavax tumbles after report on COVID-19 vaccine production delay. Like Comment Share. biopharmadive.com ...
Specialty Pharmacy and Medicines: A One-to-One Approach
May 7, 2021 ... Accessed May 7, 2021 at https://www.biopharmadive.com/news/drug-spending-increase-2018-specialty-meds/519001/; Specialty Pharmacy. APHA.
Gene Therapy and FDA Regulations - EMMA International
Feb 14, 2020 ... ... firms up policies retrieved on (01/29/2020) from https://www.biopharmadive.com/news/fda-gene-therapy-guidance-sameness-durability/571225 ...
Data is becoming the healthcare ecosystem entry fee - ZS
Jul 6, 2021 ... Nontraditional players like technology companies have been eyeing the healthcare sector for some time. They come with deep expertise in ...
About Us | Waste Dive
Explore our publications: Banking Dive · BioPharma Dive · CFO Dive · CIO Dive · Construction Dive · Cybersecurity Dive · Food Dive ·...
Johns Hopkins Psychiatry in the Media
Biogen's Alzheimer's pitch yields few converts - Biopharma Dive Constantine Lyketsos, a psychiatry and behavioral sciences professor at Johns Hopkins ...
Optimization of Lipid-Lowering Therapy for High ... - JMCP
Aug 8, 2020 ... move by rival Amgen. BioPharma Dive. February 11, 2019. Available at: https://www.biopharmadive.com/news/regeneron-sanofi-cut-pcsk9-list-.
Four Newer Antidepressants: Should You Use Them? - Psych Central
Aug 3, 2017 ... ... the agency announced it would deny an expanded indication for cognitive dysfunction (http://www.biopharmadive.com/news/in-reversalfda- ...
Medtronic embolization device hit with another Class I recall, 2 ...
Sep 22, 2021 ... Related Publications. BioPharma Dive · Healthcare Dive. Follow. Twitter · Facebook · LinkedIn · RSS. Feedback. Work email: * Message: *...
Benicar Lawsuits - Gastrointestinal Side Effects & FDA Warning
Daiichi spends $300M to settle Benicar suits, Biopharma Dive (08/2017); Update 2-FDA looking into death risk from Daiichi's Benicar, Reuters (06/2011) ...
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | 1 | H2 Headings: | 2 |
| H3 Headings: | 39 | H4 Headings: | 4 |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | 1 | Total Images: | 116 |
| Google Adsense: | Not Applicable | Google Analytics: | UA-19684343-41 |
Two Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| Getty Images | 12 | 0.619 % | No |
| via Getty | 10 | 0.516 % | No |
| sample Select | 9 | 0.464 % | No |
| view sample | 9 | 0.464 % | No |
| Select Newsletter | 9 | 0.464 % | No |
| UPDATED Oct | 6 | 0.31 % | No |
| 2021 at | 6 | 0.31 % | No |
| Weekly Every | 6 | 0.31 % | No |
| gene therapy | 5 | 0.258 % | No |
| Deep Dive | 5 | 0.258 % | No |
| Gene Therapy | 5 | 0.258 % | No |
| BioPharma Dive | 4 | 0.206 % | No |
| up to | 4 | 0.206 % | No |
| you agree | 4 | 0.206 % | No |
| to receive | 4 | 0.206 % | No |
| Terms of | 4 | 0.206 % | No |
| Images FDA | 4 | 0.206 % | No |
| least one | 4 | 0.206 % | No |
| View all | 4 | 0.206 % | No |
| agree to | 4 | 0.206 % | No |
Four Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| view sample Select Newsletter | 6 | 0.31 % | No |
| you agree to our | 4 | 0.206 % | No |
| via Getty Images FDA | 4 | 0.206 % | No |
| to our Terms of | 3 | 0.155 % | No |
| agree to our Terms | 3 | 0.155 % | No |
| our Terms of Use | 3 | 0.155 % | No |
| of Use and Privacy | 3 | 0.155 % | No |
| Use and Privacy Policy | 3 | 0.155 % | No |
| newsletter you agree to | 3 | 0.155 % | No |
| Terms of Use and | 3 | 0.155 % | No |
| our newsletter you agree | 3 | 0.155 % | No |
| By signing up to | 3 | 0.155 % | No |
| consent By signing up | 3 | 0.155 % | No |
| user consent By signing | 3 | 0.155 % | No |
| signing up to receive | 3 | 0.155 % | No |
| up to receive our | 3 | 0.155 % | No |
| receive our newsletter you | 3 | 0.155 % | No |
| to receive our newsletter | 3 | 0.155 % | No |
| and Privacy Policy You | 3 | 0.155 % | No |
| Privacy Policy You can | 3 | 0.155 % | No |
Mobile Friendly Check
Mobile Friendly : Unknown
Score : Unknown
No data to show.
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Date: Sat, 23 Oct 2021 09:06:53 GMT
Content-Type: text/html; charset=utf-8
Transfer-Encoding: chunked
Connection: keep-alive
Sniply-Options: BLOCK
Vary: Cookie
Expires: Sat, 23 Oct 2021 09:07:26 GMT
Cache-Control: max-age=120
X-Location: EU
X-Varnish: 137240127 133080767
Age: 86
Via: 1.1 varnish (Varnish/6.6)
CF-Cache-Status: DYNAMIC
Expect-CT: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=dLt/drn6ViSN0Csi2Ot5AxcG8uzDkgZEdGXRh05JDJqtQNkm6vmz1OwZaA7Tj+PXFPdF4N6Zs3YGR31i3QkvPEQyoL8NwBmflcTY2VEEcQmIyWRSgZr8QjPLEdA7Os/unbESyw8/0A=="}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 6a29cfd8c9db5b7a-FRA
Content-Encoding: gzip
Domain Information
| Domain Registrar: |
NameCheap, Inc.
|
|---|---|
| Registration Date: | 2013-05-23 1 decade 1 year 1 month ago |
| Last Modified: | 2020-11-14 3 years 7 months 2 weeks ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| sid.ns.cloudflare.com | |
173.245.59.143 | United States |
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| biopharmadive.com | A | 293 |
IP: 172.67.72.5 |
| biopharmadive.com | A | 293 |
IP: 104.26.11.62 |
| biopharmadive.com | A | 293 |
IP: 104.26.10.62 |
| biopharmadive.com | NS | 86400 |
Target: ivy.ns.cloudflare.com |
| biopharmadive.com | NS | 86400 |
Target: sid.ns.cloudflare.com |
| biopharmadive.com | SOA | 3600 |
MNAME: ivy.ns.cloudflare.com RNAME: dns.cloudflare.com Serial: 2038651958 Refresh: 10000 Retry: 2400 Expire: 604800 |
| biopharmadive.com | MX | 300 |
Priority: 30 Target: aspmx3.googlemail.com |
| biopharmadive.com | MX | 300 |
Priority: 10 Target: aspmx.l.google.com |
| biopharmadive.com | MX | 300 |
Priority: 20 Target: alt1.aspmx.l.google.com |
| biopharmadive.com | MX | 300 |
Priority: 20 Target: alt2.aspmx.l.google.com |
| biopharmadive.com | MX | 300 |
Priority: 30 Target: aspmx2.googlemail.com |
| biopharmadive.com | TXT | 300 |
TXT: facebook-domain-verification=iz27ygnlm1f tdm5tkc1ib5f1hxz99e |
| biopharmadive.com | TXT | 300 |
TXT: google-site-verification=wGWwJv0X5z-YL36 NbGCYh6tdVMq10nkQ5LSnjO1e0Rk |
| biopharmadive.com | AAAA | 293 |
IPV6: 2606:4700:20::681a:a3e |
| biopharmadive.com | AAAA | 293 |
IPV6: 2606:4700:20::ac43:4805 |
| biopharmadive.com | AAAA | 293 |
IPV6: 2606:4700:20::681a:b3e |
Alexa Traffic Rank
Alexa Search Engine Traffic
Top Organic Keyword
| 1. | marion gruber |
| 2. | biopharma dive |
| 3. | apellis |
| 4. | neuro pharmaceuticals |
| 5. | gene therapy |
Top Paid Keyword
| Not Applicable |
Top Referral Site
| 1. | inoreader.com |
| 2. | protopage.com |
| 3. | thehighwire.com |
| 4. | demorgen.be |
| 5. | thezvi.wordpress.com |
Top Destination Site
| 1. | investors.biomarin.com |
| 2. | facebook.com |
| 3. | alliancerm.org |
| 4. | amerisourcebergen.com |
| 5. | resources.industrydive.com |
Full WHOIS Lookup
Registry Domain ID:
1803374573_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.namecheap.com
Registrar URL:
http://www.namecheap.com
Updated Date:
2020-11-13T18:44:34Z
Creation Date:
2013-05-23T15:09:23Z
Registry Expiry Date:
2022-05-23T15:09:23Z
Registrar: NameCheap, Inc.
Registrar IANA
ID: 1068
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
+1.6613102107
Domain Status: clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Name Server:
IVY.NS.CLOUDFLARE.COM
Name Server:
SID.NS.CLOUDFLARE.COM
DNSSEC: unsigned
URL of the ICANN Whois
Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last
update of whois database: 2021-10-23T07:17:45Z
Similarly Ranked Websites
香港商报官网
香港商报是一份历史悠久、发行海内外的商业财经类大报，1952年新中国成立初期即在香港正式创办，至今已有近61年的风雨历程，是香港历史上最为悠久的中文报章之一，被中央政府定位为中国的国际传媒窗口：对外宣传中国，对内报道国外；以商业财经宣传为主，以政治改革报道为辅!
188,539 
$ 66,000.00
JustLend | JustLend is the first official lending platform on TRON...
JustLend is the first official lending platform on TRON where users can borrow, lend, deposit assets and earn interests. JustLend是波场网络上的首个官方借贷项目，您可以在其中进行贷款，借出，存储资产并赚取利息。
188,546 $ 66,000.00